Recent Insider Transactions - Adaptimmune Therapeutics (NASDAQ: ADAP)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ADAP Adaptimmune Therapeutics

Bertrand William C JR / officer: Chief Operating Officer

02/20/2025

Buy

$0.10

1.61M

$161K

1.61M

NASDAQ ADAP Adaptimmune Therapeutics

Bertrand William C JR / officer: Chief Operating Officer

02/20/2025

Buy

$0.0013

1.07M

$1K

1.07M

NASDAQ ADAP Adaptimmune Therapeutics

Brewer Joanna Elizabeth / officer: Chief Scientific Officer

02/20/2025

Buy

$0.10

1.61M

$161K

1.61M

NASDAQ ADAP Adaptimmune Therapeutics

Brewer Joanna Elizabeth / officer: Chief Scientific Officer

02/20/2025

Buy

$0.0013

1.07M

$1K

1.07M

NASDAQ ADAP Adaptimmune Therapeutics

Lunger John / officer: Chief Patient Supply Officer

02/20/2025

Buy

$0.10

1.61M

$161K

1.61M

NASDAQ ADAP Adaptimmune Therapeutics

Lunger John / officer: Chief Patient Supply Officer

02/20/2025

Buy

$0.0013

1.07M

$1K

1.07M

NASDAQ ADAP Adaptimmune Therapeutics

Piccina Cintia / officer: Chief Commercial Officer

02/20/2025

Buy

$0.10

1.61M

$161K

1.61M

NASDAQ ADAP Adaptimmune Therapeutics

Piccina Cintia / officer: Chief Commercial Officer

02/20/2025

Buy

$0.0013

1.07M

$1K

1.07M

NASDAQ ADAP Adaptimmune Therapeutics

Norry Elliot / officer: Chief Medical Officer

02/20/2025

Buy

$0.10

1.61M

$161K

1.61M

NASDAQ ADAP Adaptimmune Therapeutics

Norry Elliot / officer: Chief Medical Officer

02/20/2025

Buy

$0.0013

1.07M

$1K

1.07M

NASDAQ ADAP Adaptimmune Therapeutics

Rawcliffe Adrian / director, officer: Chief Executive Officer

02/20/2025

Buy

$0.10

5.14M

$514K

5.14M

NASDAQ ADAP Adaptimmune Therapeutics

Rawcliffe Adrian / director, officer: Chief Executive Officer

02/20/2025

Buy

$0.0013

3.43M

$4K

3.43M